Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03173092
Brief Title: An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)

First Submitted : May 30, 2017
First Submitted that Met QC Criteria : May 30, 2017
First Posted : June 1, 2017

Last Update Submitted that Met QC Criteria : August 12, 2019
Last Update Posted : August 13, 2019